Biotech

All Articles

2 cancer cells biotechs combine, producing international footprint

.OncoC4 is taking AcroImmune-- as well as its internal medical production capacities-- under its own...

Amgen documents 1st period 3 gain for $400M eczema medication

.Amgen has actually discussed (PDF) the very first period 3 data on its $400 thousand eczema drug, l...

Biogen, UCB record period 3 lupus win after neglecting earlier test

.Biogen as well as UCB's bet one's bottom dollar advancing into phase 3 astride a failed study wants...

Aptadir really hopes brand-new RNA preventions may turn around complicated cancers

.Italian biotech Aptadir Rehabs has introduced along with the pledge that its pipe of preclinical RN...

Wave surfs DMD excellence to regulatory authorities' doors, delivering stockpile

.Wave Lifestyle Sciences has actually satisfied its goal in a Duchenne muscular dystrophy (DMD) stud...

Sanofi tweezes brand-new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma layer, usi...

Achilles splashes tissue therapy program, braces for discharges after missing 'office practicality' objectives

.Achilles Therapeutics has torn up its tactic. The English biotech is actually stopping work on its ...

Aligos proclaims period 2 MASH succeed, slashing liver excess fat as much as 46%

.Aligos Therapeutics is actually advertising a midstage succeed in metabolic-dysfunction connected s...

Basilea credit ratings $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's job creating brand-new antifungals has actually received a significant impr...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Possessing actually gathered up the united state civil rights to Capricor Therapeutics' late-stage ...